Propel Bio Management, LLC Diversified Active

Location: Los Angeles, CA

CIK: 0001969764 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value: $101M (100.0% shares, 0.0% debt)

Holdings (21)

PAGP PLAINS GP HOLDINGS LP-CL 23.2%

Value $23.39M Shares 1,272,360 Est. Cost $18.82 Unrealized —

MDGL MADRIGAL PHARMACEUTICALS 13.2%

Value $13.28M Shares 43,032 Est. Cost $193.31 Unrealized +45.5%

— AKERO THERAPEUTICS INC 9.5%

Value $9.563M Shares 343,729 Est. Cost $24.86 Unrealized —

ACHV ACHIEVE LIFE SCIENCES INC 8.6%

Value $8.635M Shares 2,453,092 Est. Cost $4.44 Unrealized +2.1%

— APPLIED THERAPEUTICS INC 8.2%

Value $8.233M Shares 9,615,420 Est. Cost $2.89 Unrealized —

PHAT PHATHOM PHARMACEUTICALS I 8.0%

Value $8.038M Shares 989,927 Est. Cost $9.02 Unrealized +37.3%

TCRX TSCAN THERAPEUTICS INC 6.3%

Value $6.345M Shares 2,087,139 Est. Cost $4.58 Unrealized -1.0%

RNAM AVIDITY BIOSCIENCES INC 5.2%

Value $5.191M Shares 178,500 Est. Cost $6.68 Unrealized +525.2%

ARDX ARDELYX INC 4.8%

Value $4.821M Shares 950,947 Est. Cost $5.46 Unrealized +1.1%

ABEO ABEONA THERAPEUTICS INC 3.5%

Value $3.476M Shares 624,022 Est. Cost $5.10 Unrealized +20.6%

SNDX SYNDAX PHARMACEUTICALS IN 2.4%

Value $2.423M Shares 183,259 Est. Cost $20.44 Unrealized -16.3%

KYMR KYMERA THERAPEUTICS INC 2.3%

Value $2.267M Shares 56,359 Est. Cost $17.88 Unrealized +152.6%

ZVRA ZEVRA THERAPEUTICS INC 1.5%

Value $1.5M Shares 179,874 Est. Cost $6.78 Unrealized +25.9%

KURA KURA ONCOLOGY INC 1.1%

Value $1.132M Shares 130,000 Est. Cost $9.83 Unrealized +46.3%

— ATHIRA PHARMA INC 0.9%

Value $876K Shares 1,492,792 Est. Cost $2.43 Unrealized —

— EIGER BIOPHARMACEUTICALS 0.8%

Value $765K Shares 146,381 Est. Cost $5.00 Unrealized —

JSPR JASPER THERAPEUTICS INC 0.4%

Value $428K Shares 20,000 Est. Cost $20.82 Unrealized 0.0%

DCTH DELCATH SYSTEMS INC 0.2%

Value $205K Shares 17,000 Est. Cost $10.55 Unrealized 0.0%

CMPS COMPASS PATHWAYS PLC 0.1%

Value $95,290 Shares 25,209 Est. Cost $6.30 Unrealized —

MATPF MAAT PHARMA SACA 0.0%

Value $25,082 Shares 3,151 Est. Cost $7.55 Unrealized —

— CHINOOK THERAPEUTICS 0.0%

Value $9,750 Shares 79,357 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PAGP	PLAINS GP HOLDINGS LP-CL	1,272,360	$23.39M	23.2%	$18.82	—	COMM	72651A207
MDGL	MADRIGAL PHARMACEUTICALS	43,032	$13.28M	13.2%	$193.31	+45.5%	COMM	558868105
—	AKERO THERAPEUTICS INC	343,729	$9.563M	9.5%	$24.86	—	COMM	00973Y108
ACHV	ACHIEVE LIFE SCIENCES INC	2,453,092	$8.635M	8.6%	$4.44	+2.1%	COMM	004468500
—	APPLIED THERAPEUTICS INC	9,615,420	$8.233M	8.2%	$2.89	—	COMM	03828A101
PHAT	PHATHOM PHARMACEUTICALS I	989,927	$8.038M	8.0%	$9.02	+37.3%	COMM	71722W107
TCRX	TSCAN THERAPEUTICS INC	2,087,139	$6.345M	6.3%	$4.58	-1.0%	COMM	89854M101
RNAM	AVIDITY BIOSCIENCES INC	178,500	$5.191M	5.2%	$6.68	+525.2%	COMM	05370A108
ARDX	ARDELYX INC	950,947	$4.821M	4.8%	$5.46	+1.1%	COMM	039697107
ABEO	ABEONA THERAPEUTICS INC	624,022	$3.476M	3.5%	$5.10	+20.6%	COMM	00289Y206
SNDX	SYNDAX PHARMACEUTICALS IN	183,259	$2.423M	2.4%	$20.44	-16.3%	COMM	87164F105
KYMR	KYMERA THERAPEUTICS INC	56,359	$2.267M	2.3%	$17.88	+152.6%	COMM	501575104
ZVRA	ZEVRA THERAPEUTICS INC	179,874	$1.5M	1.5%	$6.78	+25.9%	COMM	488445206
KURA	KURA ONCOLOGY INC	130,000	$1.132M	1.1%	$9.83	+46.3%	COMM	50127T109
—	ATHIRA PHARMA INC	1,492,792	$876K	0.9%	$2.43	—	COMM	04746L104
—	EIGER BIOPHARMACEUTICALS	146,381	$765K	0.8%	$5.00	—	COMM	28249U204
JSPR	JASPER THERAPEUTICS INC	20,000	$428K	0.4%	$20.82	0.0%	COMM	471871202
DCTH	DELCATH SYSTEMS INC	17,000	$205K	0.2%	$10.55	0.0%	COMM	24661P807
CMPS	COMPASS PATHWAYS PLC	25,209	$95,290	0.1%	$6.30	—	COMM	20451W101
MATPF	MAAT PHARMA SACA	3,151	$25,082	0.0%	$7.55	—	COMM	F5888J116
—	CHINOOK THERAPEUTICS	79,357	$9,750	0.0%	—	—	COMM	169CVR016